Innovative blood test boosts accuracy of lung cancer screening

FHS
June 11, 2024
9:40 am

A blood-based, cell-free deoxyribonucleic acid (cfDNA) fragmentome assay for lung cancer detection.

Prelude and AbCellera jump on the ADC train with partnership – Pharmaceutical Technology

Prelude will be responsible for the clinical development and global commercialisation while AbCellera will lead the manufacturing activities for the ADCs. Image Credit: Alpha Tauri

November 2, 2023

WHO recommends dropping component of many flu vaccines

The World Health Organization has recommended dropping a component of many flu vaccines because the viruses it protects against appear to have been driven into

September 29, 2023

China approves Eli Lilly’s weight loss drug as country launches obesity awareness campaign

Eli Lilly’s tirzepatide has been approved for weight management in China, entering what’s expected to be a substantial market for GLP-1s. Tirzepatide — marketed in

July 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.